Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 127 | 0 | 0 | 0 | 26,691 |
| Cost of Goods | N/A | N/A | N/A | N/A | 2,500 |
| Gross Profit | 127 | N/A | N/A | N/A | 24,191 |
| Operating Expenses | 29,530 | 28,241 | 22,886 | 19,324 | 18,440 |
| Operating Income | -29,403 | -28,241 | -22,886 | -19,324 | 6,251 |
| Interest Expense | 766 | 604 | 518 | 0 | 0 |
| Other Income | -7 | -4 | 580 | 344 | 680 |
| Pre-tax Income | -30,176 | -28,849 | -22,824 | -18,980 | 6,931 |
| Net Income Continuous | -30,176 | -28,849 | -22,824 | -18,980 | 6,931 |
| Net Income | $-30,176 | $-28,849 | $-22,824 | $-18,980 | $6,931 |
| EPS Basic Total Ops | -0.79 | -0.75 | -0.60 | -0.51 | 0.19 |
| EPS Basic Continuous Ops | -0.79 | -0.75 | -0.60 | -0.51 | 0.19 |
| EPS Diluted Total Ops | -0.79 | -0.75 | -0.60 | -0.50 | 0.18 |
| EPS Diluted Continuous Ops | -0.79 | -0.75 | -0.60 | -0.51 | 0.18 |
| EPS Diluted Before Non-Recurring Items | -0.79 | -0.75 | -0.60 | -0.51 | 0.18 |
| EBITDA(a) | $-29,119 | $-27,879 | $-22,655 | $-19,192 | $6,271 |